Successful Treatment of Immunodeficiency-Associated EBV-Negative Lymphoproliferative Disorders in Rheumatoid Arthritis by Methotrexate Withdrawal and Prevention of its Relapse by Rituximab Administration-Reference-Cited by-同舟云学术

Successful Treatment of Immunodeficiency-Associated EBV-Negative Lymphoproliferative Disorders in Rheumatoid Arthritis by Methotrexate Withdrawal and Prevention of its Relapse by Rituximab Administration

Published:2012 Issue:3 Volume:52 Page:193-198
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Kawano Noriaki,Ono Nobuyuki,Yoshida Shuro,Kuriyama Takuro,Yamashita Kiyoshi,Beppu Kiichiro,Shimao Yoshiya,Marutsuka Kosuke,Ueda Yuji,Ueda Akira

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Reference14 articles.

1. 1 Emery P: Treatment of rheumatoid arthritis. BMJ 332:152-155, 2006

2. 5 Salliot C, van der Heijde D: Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis : a systematic literature research. Ann Rheum Dis 68:1100-1104, 2009

3. 6 Wessels JA, Huizinga TW, Guchelaar HJ: Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 47:249-255, 2008

4. 7 Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L: Rheumatoid arthritis and malignant lymphomas. Curr Opin Rheumatol 16:254-261, 2004

5. 8 Wolfe F, Michaud K: Lymphoma in rheumatoid arthritis : The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50:1740-1751, 2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rheumatoid arthritis relapse in patients with other iatrogenic immunodeficiency-associated lymphoproliferative disorders and its treatment;Modern Rheumatology;2021-11-02

2. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders;Journal of Clinical and Experimental Hematopathology;2019

3. Treatment of advanced stage methotrexate-associated lymphoproliferative disorders (MTX-LPDs) with methotrexate discontinuation;BMJ Case Reports;2018-12

4. Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis;Rheumatology and Therapy;2017-05-15

5. Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort;Clinical Rheumatology;2017-04-28